Unicycive Therapeutics Inc (UNCY) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Unicycive Therapeutics Inc  (NASDAQ: UNCY)

Unicycive Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information




UNCY Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) - 71.22 % 67.02 % 45.49 %
Gross Margin (Q2 TTM) - 70.11 % 64.47 % 45.4 %
Gross Profit Margin 5 Yr. Avg. - 64.59 % 63.22 % 45.98 %
EBITDA Margin (Q2 MRQ) - 27.94 % 22.3 % 19.74 %
EBITDA Margin (Q2 TTM) - 25.75 % 20.47 % 17.69 %
EBITDA Margin 5 Yr. Avg. - 32.45 % 25.19 % 20.74 %
Operating Margin (Q2 MRQ) - 22.61 % 18.84 % 16.02 %
Operating Margin (Q2 TTM) - 18.59 % 15.8 % 15.3 %
Operating Margin 5 Yr. Avg. - 14.79 % 13.75 % 15.93 %
Pre-Tax Profit Margin (Q2 MRQ) - 19.1 % 14.06 % 12.72 %
Pre-Tax Profit Margin (Q2 TTM) - 16.37 % 12.04 % 11.96 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12.75 % 10.33 % 11.45 %
Net Margin (Q2 MRQ) - 15.76 % 11.31 % 10.33 %
Net Margin (Q2 TTM) - 14.95 % 10.68 % 9.71 %
Net Margin 5 Yr. Avg. - 8.75 % 7.66 % 9.19 %